Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Technical Report
Nature Medicine  11, 899 - 904 (2005)
Published online: 19 June 2005; | doi:10.1038/nm1264

A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression

Adriaan D Bins1, Annelies Jorritsma1, Monika C Wolkers1, Chien-Fu Hung2, T-C Wu2, Ton N M Schumacher1 & John B A G Haanen1

1  Department of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

2  Department of Pathology, The Johns Hopkins Medical Institution, The Johns Hopkins University School of Medicine, Ross Research Building, Room 512, 720 Rutland Avenue, Baltimore, Maryland 21205, USA.

Correspondence should be addressed to John B A G Haanen j.haanen@nki.nl

Induction of immunity after DNA vaccination is generally considered a slow process. Here we show that DNA delivery to the skin results in a highly transient pulse of antigen expression. Based on this information, we developed a new rapid and potent intradermal DNA vaccination method. By short-interval intradermal DNA delivery, robust T-cell responses, of a magnitude sufficient to reject established subcutaneous tumors, are generated within 12 d. Moreover, this vaccination strategy confers protecting humoral immunity against influenza A infection within 2 weeks after the start of vaccination. The strength and speed of this newly developed strategy will be beneficial in situations in which immunity is required in the shortest possible time.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Research Highlights

Nature Immunology News and Views (01 Aug 2005)

Paving the way towards DNA vaccines

Nature Medicine News and Views (01 Jun 1995)

RESEARCH

Activation of calcium/calmodulin-dependent protein kinases after traumatic brain injury

Journal of Cerebral Blood Flow & Metabolism Original Article

Design and use of conditional MHC class I ligands

Nature Medicine Technical Report (01 Mar 2006)

See all 63 matches for Research
 Top
Abstract
Previous
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

naturejobs

Figures & Tables
Supplementary info
Export citation
natureproducts

Search buyers guide:

 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2005 Nature Publishing Group | Privacy policy